Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure
Authors:
Open Access
- 1 October 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 18 (10) , 1620-1625
Abstract
Increased activity of pro-inflammatory cytokines in the circulation has been observed in many, though not all, patients with congestive heart failure. To identify the predictors of cytokine activation in congestive heart failure, we assessed the relationship of peripheral and hepatic venous cytokines to central haemodynamics, neuroendocrine status and intermediary metabolism in patients with moderate or severe congestive heart failure. Concentrations of tumour necrosis factor-α, soluble tumour necrosis factor-receptor II and interleukin 6 were measured from peripheral and hepatic venous plasma in 58 adult cardiac patients, of whom 44 had congestive heart failure, undergoing heart catheterization, echocardiography and assessment of selected neuroendocrine and metabolic characteristics. Peripheral venous soluble tumour necrosis factor-receptor II was directly related to NYHA class (rs=0·46 P>0·001) and inversely to 6-min walking distance (rs−0·46, P>0·001). Peripheral venous tumour necrosis factor-α was related to 6-min walking distance (rs=−0·37, P>0·01), but like soluble tumour necrosis factor-receptor II, was unrelated to other haemodynamic and neuroendocrine measurements. Peripheral venous interleukin 6 correlated with NYHA class (rs=0·66, P>0·001) and 6-min walking distance (rs −0·52, P>0·001). In addition, interleukin 6 was related to right atrial pressure (rs0·55, P>0·001 pulmonary artery wedge pressure (rs=−0·50, P>0·001 and left ventricular ejection fraction (rs=−0·39, P>0·01); in multivariate analysis, only right atrial pressure was an independent predictor of interleukin 6 concentration (P>0·001). Comparisons between patients with and without congestive heart failure showed significantly higher hepatic venous tumour necrosis factor-α, soluble tumour necrosis factor-receptor II and interleukin 6 in the heart failure group; the differences in peripheral venous cytokines were less consistent. In cardiac patients, increased plasma tumour necrosis factor-α and soluble tumour necrosis factor-receptor II are associated with symptoms of heart failure and poor exercise capacity, while the most important predictor of increased interleukin 6 is elevated systemic venous pressure. Different but still unknown mechanisms may be responsible for the increased release of cytokines in congestive heart failure.Keywords
This publication has 18 references indexed in Scilit:
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJACC, 1996
- Blood ketone bodies in congestive heart failureJACC, 1996
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)JACC, 1996
- Increased levels of serum neoprotein and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alphaJACC, 1993
- Through thick and thin: Wasting, obesity, and TNFαCell, 1993
- Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.Journal of Experimental Medicine, 1992
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- The theoretical bases of indirect calorimetry: A reviewMetabolism, 1988